Navigation Links
Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study

SAN FRANCISCO, June 05, 2007 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that it will hold a teleconference at 8:30 a.m. Eastern time on Monday, June 11, to discuss top-line 12-month results from its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Dimebon(TM), its lead product candidate, in Alzheimer's disease.

Rachelle Doody, M.D., Ph.D., lead investigator for the study, will present the 12-month results for the first time at a scientific meeting at the 2007 Alzheimer's Association International Conference on Prevention of Dementia in Washington, D.C. Dr. Doody will present the data (abstract #S3-02-03, "Results of a One-Year Randomized, Placebo-Controlled Trial of Dimebon for the Treatment of Mild to Moderate Alzheimer's Disease") on Tuesday, June 12, at 10:00 a.m. Eastern time during the symposium session on "Emerging Compounds." Dr. Doody holds the Effie Marie Cain Chair in Alzheimer's Disease Research at the Alzheimer's Disease and Memory Disorders Center, in Houston.

The Alzheimer's Association, sponsor of the Prevention of Dementia conference, has selected the Dimebon data for inclusion in a news briefing to be held during the conference. That news briefing, which will focus on Alzheimer's disease therapies and be open to credentialed reporters, writers or editors from recognized external print, broadcast, syndicated or online news organizations, will take place at 12:00 p.m. Eastern time on Monday, June 11.

Teleconference/Webcast Details

To participate in the live call on Monday, June 11, at 8:30 a.m. Eastern time by telephone, please dial 800-565-5442 from the U.S. or 913-312-1298 internationally. A telephone replay will be available for seven days following the conclusion of the call by dialing 888-203-1112 from the U.S. or 719-457-0820 for international callers and entering passcode 4782383. Individuals interested in listening to the l
'"/>




Page: 1 2 3

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
3. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimers Disease Conference
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
8. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
9. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. Tercica to Present at Investment Conferences

Post Your Comments:
(Date:11/23/2009)...-BridgePointMedicalannouncedtodaythatitreceivedEur...eripheralChronicTotalOcclusion(CTO)CrossingSystemc...eStingray®CTORe-EntrySystem.TheBridgePointSys...edtonavigatehighlydiseasedarteriesinpreparationfor..., TheNationalHeart,LungandBloodInstitute(NHLBI)es...
(Date:11/23/2009)...re-FirstCall/-- CumberlandPharmaceuticalsInc. (CPI...astudyevaluatingthesafetyandefficacyofCaldolor( ib...npatients. ,, Statisticalsignificancewasachieve...soverthefirst24hoursoftreatment.Thestudyevaluated6...ringmorethan10percenttotalbodysurfacearea.Otherpar...
(Date:11/23/2009)...--AMDLASERSannouncedthisweekthatitcontinueswithano...restigiousindustry-leaderDr.LarryRosenthalandAesth...vesofttissuediodelaserusedduringallinternationaled...ntists. ,, (Photo: http://www.newscom.com/cgi-b...asurethatIproudlyannounceourpartnership.Softtissue...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 1Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 2New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 1New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 2New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 3No Economic Slowdown for Expanding U S Medical Manufacturer 13644 1No Economic Slowdown for Expanding U S Medical Manufacturer 13644 2
...--(BUSINESS WIRE)--Apr 5, 2007 - MIV Therapeutics ...f next-generation,biocompatible coatings and advan...s and other implantable medical devices, today,ann...confirmed that,merging Biosync Scientific,s certif... acquired, with the Company,s polymer-free drug,de...
...sters Relating to Company Oncology Programs to be ...2007,/PRNewswire-FirstCall/ -- Cytokinetics, Incor...ng non-clinical data will be,presented at the 2007...ncer Research (AACR) to be held from April 14- 18,...d to multiple oncology,programs at Cytokinetics an...
Other Medicine Technology:MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 2MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 3MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7
(Date:11/23/2009)...tedConcordiaDental,oneofthenation,slargestdentalin...unitedconcordia.comwhichprovidesimprovedaccesstoin.... ,, "Thesiteboastsacleandesign,betterorganizat...itorsfindinformationquicklyandeasily,"saidPaulJone...."Fresh,relevantcontent,coupledwithanimprovedeaseo...
(Date:11/23/2009)...ade,M.D.announcesthenewlyenhancedCyberKnifeequipme...fMiami,( www.cyberknifemiami.com ). ,, TheCyb...sedoseofradiationthatkillscancercellswithnoinvasiv...om30minutestoonehour,andisusuallycompletedin1-5tre...intheSoutheasternU.S.,theMiamifacilityhasledtheway...
(Date:11/23/2009)...al and physical health , , MONDAY, Nov. ...as many years off your life as smoking does, a new...pression and anxiety appears to be better for long...to their conclusions after analyzing death records...he four years after the survey, the death rate was...
(Date:11/23/2009)...ovember issue of GIE: Gastrointestinal Endoscopy ...the American Society for Gastrointestinal Endoscop... that Barrett,s esophagus was detected in six perc...reening. Also in this issue, two studies examined ...ce, in the largest single-center experience to dat...
(Date:11/23/2009)...ystem study has found that one out of five Type 2 ...ounds or more overweight. , Researchers reported...etes are obese, and 20.7 percent are morbidly obes...tes, 1 in 3 is morbidly obese. , "The rate of mo...ing at a very alarming rate, and this has substant...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2
...d of protection against bird flu has been studied ...at the University of Rochester. // This involves a...emic of bird flu hits, it would take months to dev...accination. An initial dose of the vaccine is give...
...st advanced nations of the world today, Britain ha...e most 'obese nation in Europe' last week. //In a ... more than one –fourth of the nation's population ...ards improving people's quality of life through go...
...rds today throughout the country are 'Dengue' an...brought on by the bite of an infected// Aedes aeg...olling in several Indian states. Dengue is the m...ning to go out of hand unless a formidable solutio...
...eople have died of dengue fever in the Dominican R... the health authorities announced a drop in the nu...al patients hit by the disease this year is nearly...ojas said a large number of student volunteers wil...
...avels that other factors play a strong role along ...Down's Syndrome.// Many older women who have been ...ound out that they are pregnant often find themsel...us (unborn developing baby) being malformed or men...
...rs at the Launceston General Hospital have develop... According to the director of the LGH Dementia Res...luid from the brain can treat one type of dementia... and women of the age 58-92 years, from the hospit...
Other Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Cause of ‘Down Syndrome’ cannot be pinned down to maternal age alo 2
Pefakit TAFI
Pefakit TAFI Calibrator/Control
QuikCoag Control 2
...to address hematology needs in today's changing la..., closed-tube sampling, small sample requirements,... modern hematology lab. New challenges have made f...nt, and simplification of data interpretation nece...
Medicine Products: